Insider Transactions in Q3 2024 at Vyne Therapeutics Inc. (VYNE)
Insider Transaction List (Q3 2024)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Sep 30
2024
|
Mutya Harsch CHIEF LEGAL OFFICER AND GC |
SELL
Payment of exercise price or tax liability
|
Direct |
105
-0.07%
|
$105
$1.88 P/Share
|
|
Sep 30
2024
|
David Domzalski PRESIDENT AND CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
685
-0.14%
|
$685
$1.88 P/Share
|
|
Sep 30
2024
|
Iain Stuart CHIEF SCIENTIFIC OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
109
-0.08%
|
$109
$1.88 P/Share
|
|
Sep 30
2024
|
Tyler Zeronda CHIEF FINANCIAL OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
84
-0.06%
|
$84
$1.88 P/Share
|
|
Jul 01
2024
|
David Domzalski PRESIDENT AND CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
935
-0.19%
|
$935
$1.92 P/Share
|
|
Jul 01
2024
|
Mutya Harsch CHIEF LEGAL OFFICER AND GC |
SELL
Payment of exercise price or tax liability
|
Direct |
143
-0.1%
|
$143
$1.92 P/Share
|
|
Jul 01
2024
|
Iain Stuart CHIEF SCIENTIFIC OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
138
-0.1%
|
$138
$1.92 P/Share
|
|
Jul 01
2024
|
Tyler Zeronda CHIEF FINANCIAL OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
92
-0.07%
|
$92
$1.92 P/Share
|